Rehmann Capital Advisory Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.48M | Buy |
11,708
+58
| +0.5% | +$7.64K | 0.07% | 202 |
|
|
2026
Q1 | $1.62M | Buy |
11,650
+356
| +3% | +$49.9K | 0.08% | 169 |
|
|
2025
Q4 | $1.39M | Buy |
11,294
+853
| +8% | +$104K | 0.07% | 185 |
|
|
2025
Q3 | $1.16M | Buy |
+10,441
| New | +$1.19M | 0.06% | 205 |
|
|
2025
Q2 | – | Sell |
-10,073
| Closed | -$1.13M | – | 629 |
|
|
2025
Q1 | $1.13M | Buy |
10,073
+81
| +0.8% | +$8.36K | 0.07% | 205 |
|
|
2024
Q4 | $923K | Buy |
9,992
+366
| +4% | +$33K | 0.06% | 229 |
|
|
2024
Q3 | $807K | Buy |
9,626
+333
| +4% | +$25.4K | 0.05% | 246 |
|
|
2024
Q2 | $638K | Sell |
9,293
-1,117
| -11% | -$74.5K | 0.05% | 278 |
|
|
2024
Q1 | $763K | Sell |
10,410
-2,048
| -16% | -$157K | 0.06% | 238 |
|
|
2023
Q4 | $1.01M | Buy |
12,458
+450
| +4% | +$35K | 0.08% | 190 |
|
|
2023
Q3 | $900K | Sell |
12,008
-717
| -6% | -$55.1K | 0.08% | 187 |
|
|
2023
Q2 | $981K | Buy |
12,725
+76
| +0.6% | +$6.06K | 0.09% | 193 |
|
|
2023
Q1 | $1.05M | Buy |
12,649
+78
| +0.6% | +$6.46K | 0.1% | 178 |
|
|
2022
Q4 | $1.08M | Buy |
12,571
+143
| +1% | +$11.3K | 0.11% | 163 |
|
|
2022
Q3 | $767K | Buy |
12,428
+999
| +9% | +$63K | 0.09% | 206 |
|
|
2022
Q2 | $706K | Buy |
11,429
+2,157
| +23% | +$134K | 0.08% | 219 |
|
|
2022
Q1 | $566K | Sell |
9,272
-2,300
| -20% | -$147K | 0.05% | 287 |
|
|
2021
Q4 | $844K | Buy |
11,572
+488
| +4% | +$33.6K | 0.08% | 222 |
|
|
2021
Q3 | $774K | Sell |
11,084
-1,277
| -10% | -$89.7K | 0.07% | 232 |
|
|
2021
Q2 | $852K | Buy |
12,361
+423
| +4% | +$28.2K | 0.08% | 210 |
|
|
2021
Q1 | $785K | Sell |
11,938
-503
| -4% | -$32.4K | 0.08% | 208 |
|
|
2020
Q4 | $725K | Sell |
12,441
-11,375
| -48% | -$686K | 0.08% | 201 |
|
|
2020
Q3 | $1.5M | Buy |
23,816
+10,227
| +75% | +$709K | 0.19% | 97 |
|
|
2020
Q2 | $1.05M | Buy |
13,589
+887
| +7% | +$68K | 0.14% | 126 |
|
|
2020
Q1 | $950K | Buy |
+12,702
| New | +$878K | 0.16% | 115 |
|
|
2019
Q3 | $737K | Sell |
11,624
-152
| -1% | -$9.94K | 0.09% | 120 |
|
|
2019
Q2 | $796K | Sell |
11,776
-130
| -1% | -$8.55K | 0.1% | 168 |
|
|
2019
Q1 | $774K | Buy |
11,906
+203
| +2% | +$13.5K | 0.1% | 162 |
|
|
2018
Q4 | $732K | Sell |
11,703
-1,570
| -12% | -$110K | 0.11% | 97 |
|
|
2018
Q3 | $1.02M | Sell |
13,273
-651
| -5% | -$49.2K | 0.14% | 123 |
|
|
2018
Q2 | $986K | Sell |
13,924
-9,028
| -39% | -$638K | 0.14% | 119 |
|
|
2018
Q1 | $1.73M | Sell |
22,952
-723
| -3% | -$57.5K | 0.27% | 68 |
|
|
2017
Q4 | $1.7M | Sell |
23,675
-750
| -3% | -$57K | 0.29% | 69 |
|
|
2017
Q3 | $1.98M | Buy |
24,425
+982
| +4% | +$75.1K | 0.36% | 60 |
|
|
2017
Q2 | $1.66M | Sell |
23,443
-836
| -3% | -$55.6K | 0.32% | 66 |
|
|
2017
Q1 | $1.65M | Buy |
24,279
+4,423
| +22% | +$311K | 0.28% | 73 |
|
|
2016
Q4 | $1.42M | Buy |
19,856
+4,874
| +33% | +$362K | 0.26% | 77 |
|
|
2016
Q3 | $1.19M | Sell |
14,982
-3,983
| -21% | -$324K | 0.23% | 91 |
|
|
2016
Q2 | $1.58M | Sell |
18,965
-1,194
| -6% | -$106K | 0.3% | 69 |
|
|
2016
Q1 | $1.85M | Buy |
20,159
+798
| +4% | +$72K | 0.36% | 58 |
|
|
2015
Q4 | $1.96M | Sell |
19,361
-2,032
| -9% | -$211K | 0.41% | 47 |
|
|
2015
Q3 | $2.1M | Buy |
21,393
+1,473
| +7% | +$164K | 0.48% | 47 |
|
|
2015
Q2 | $2.33M | Buy |
19,920
+2,448
| +14% | +$267K | 0.53% | 41 |
|
|
2015
Q1 | $1.72M | Buy |
17,472
+838
| +5% | +$85.1K | 0.39% | 54 |
|
|
2014
Q4 | $1.57M | Sell |
16,634
-770
| -4% | -$79.6K | 0.36% | 58 |
|
|
2014
Q3 | $1.85M | Buy |
17,404
+899
| +5% | +$88K | 0.44% | 48 |
|
|
2014
Q2 | $1.37M | Buy |
16,505
+922
| +6% | +$71.8K | 0.33% | 67 |
|
|
2014
Q1 | $1.1M | Buy |
15,583
+1,996
| +15% | +$157K | 0.3% | 67 |
|
|
2013
Q4 | $1.02M | Sell |
13,587
-343
| -2% | -$23.9K | 0.31% | 71 |
|
|
2013
Q3 | $876K | Sell |
13,930
-162
| -1% | -$9.68K | 0.28% | 72 |
|
|
2013
Q2 | $722K | Buy |
+14,092
| New | +$735K | 0.25% | 78 |
|
Other funds holding GILD
Rehmann Capital Advisory Group's GILD Position: Q2 2026 in Review
Rehmann Capital Advisory Group increased its Gilead Sciences (GILD) stake by 0.5% in Q2 2026, buying an estimated $7.64K and bringing the position to 11,708 shares worth $1.48M. The position accounts for 0.07% of the portfolio, ranked #202.
Rehmann Capital Advisory Group first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.33M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Rehmann Capital Advisory Group held 11,708 shares of Gilead Sciences worth $1.48M as of Q2 2026.
- Rehmann Capital Advisory Group bought 58 Gilead Sciences shares in Q2 2026, an estimated $7.64K.
- Gilead Sciences made up 0.07% of Rehmann Capital Advisory Group's portfolio in Q2 2026, its #202 holding.
- Rehmann Capital Advisory Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- Rehmann Capital Advisory Group's Gilead Sciences position peaked at $2.33M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Rehmann Capital Advisory Group's 13F filing for Q2 2026, filed 20 Aug 2026.